← back to search

Kateryna Krytska

Thomas Jefferson University · US
Area of research
Neurology · Cancer Research
Research interest
Research interests include Medicine, Refractory (planetary science), Neuroblastoma, Preclinical testing, Clinical trial, and Disease.
h-index
citations
338
works
3
NIH funding
primary concept
email

Recent publications

Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results
Nature Medicine 2023cited by 121position: middledoi
Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma
Nature Communications 2023cited by 45position: middledoi
Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design
Cell Reports 2019cited by 172position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 1 papers (2023–2023) · 1 papers (2023–2023)Courtney M. Smith · Yale Cancer Center1 papers (2023–2023) · 1 papers (2023–2023)Kelly C. Goldsmith · Emory University1 papers (2023–2023)Mark A Lemmon · Yale Cancer Center1 papers (2023–2023) · 1 papers (2023–2023)John M. Maris · ASML (Netherlands)1 papers (2023–2023)Mark Gerelus · Wake Forest University1 papers (2023–2023) · 1 papers (2023–2023)Smita Matkar · UPMC Hillman Cancer Center1 papers (2023–2023)Julie R. Park · University of Tennessee at Knoxville1 papers (2023–2023)Araz Marachelian · University of Southern California1 papers (2023–2023)Megan A Wu · Yale Cancer Center1 papers (2023–2023) · 1 papers (2023–2023)Yaël P. Mossé · St. Jude Children's Research Hospital1 papers (2023–2023)Dean C. Pavlick · Foundation Medicine (United States)1 papers (2023–2023) · 1 papers (2023–2023) · 1 papers (2023–2023)Zaritza O. Petrova · Yale Cancer Center1 papers (2023–2023)